0
Article Tier 2 Environmental Sources Human Health Effects Nanoplastics Remediation Sign in to save

MassBalance Tracing of In Vivo Biodistribution,Relocation, and Excretion of Europium-Doped Micro/Nanoplastics inRats

AI summary Read the abstract

This rat study used europium-labeled micro- and nanoplastics to track particle distribution in the body after intravenous administration, finding that most accumulated in the liver and spleen with very little reaching the brain or heart. The results suggest that standard biological filtration processes govern microplastic distribution following classical size-dependent rules.

The discovery of micro/nanoplastics (MNPs) in the human circulatory system raises great health concerns. It is generally believed the in vivo transport and fate of MNPs are size dependent regulated by various physiological barriers, but recently, increasing reports of MNP accumulation in the brain or excreted through urine challenges this knowledge. Herein, the biodistribution, relocation, and excretion of intravenously administered MNPs were quantitatively traced in female rats for 3 months based on mass balance assessment using europium-doped polystyrene MNPs. With an overall recovery ∼90%, MNPs were mainly found in liver and spleen but seldom in brain and heart, indicating in vivo MNP transport follows classical size-dependent rules. Muscles with low concentrations of MNPs become the second largest long-term sink after the liver due to their high overall mass within the body. Dose-dependent accumulation was observed in RES (reticuloendothelial system) organs, while similar concentrations in low- and high-dose treatments imply a low maximum accumulation for MNP in the heart and brain. Although only minor toxicity effects were observed, just ∼80% of 77 nm and ∼15% of 300 and 2000 nm MNPs were exclusively excreted through feces, mostly in the first 3 weeks following a growth-curve pattern, thereby demonstrating long-term accumulation and potential health concerns.

More Papers Like This

Article Tier 2

Mass Balance Tracing of In Vivo Biodistribution, Relocation, and Excretion of Europium-Doped Micro/Nanoplastics in Rats

AI summary Read the abstract

Scientists injected tiny plastic particles into rats and tracked where they went in the body for three months. Most plastic particles collected in the liver and spleen, with smaller particles being harder for the body to get rid of—only 80% of the smallest particles were eliminated compared to just 15% of larger ones. This suggests that microplastics from food, water, and air could build up in our organs over time, though the long-term health effects are still unknown.

Article Tier 2

Semiquantitative assessment of the distribution of microplastic particles in the body during acute exposure

AI summary Read the abstract

Researchers developed and validated a semi-quantitative method to assess microplastic distribution across organs in rats under acute exposure conditions, using fluorescent particles of three sizes (100, 500, 1000 nm) to map accumulation patterns — finding size-dependent biodistribution with smaller particles reaching more tissues.

Article Tier 2

Biodistribution of europium-doped polystyrene nanoplastics in a model invertebrate organism

AI summary Read the abstract

This study used europium-doped polystyrene nanoplastics tracked by laser ablation inductively coupled plasma mass spectrometry to map biodistribution of plastic nanoparticles in a model invertebrate organism. The labeled tracer approach enabled precise organ-level mapping of nanoplastic distribution, revealing where plastic nanoparticles accumulate after exposure.

Article Tier 2

Biodistribution of nanoplastics in mice: advancing analytical techniques using metal-doped plastics

AI summary Read the abstract

Researchers developed a new analytical method using palladium-doped nanoplastics to track where plastic particles go in the body after ingestion in mice. They found that after short-term exposure, most particles passed through the digestive system and were excreted, but longer-term exposure led to accumulation in body tissues. The study advances the ability to detect and trace nanoplastics at extremely small concentrations in biological samples.

Article Tier 2

Systemic translocation of micro- and nanoplastics in humans: Evidence, mechanisms and future perspectives

AI summary Read the abstract

This review summarizes existing research on tiny plastic particles found in human tissues like the placenta, lungs, liver, kidneys, and brain. It examines how these particles might move through the body, based mainly on lab and animal studies, and notes that detection methods and human evidence still have major limitations.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper